EAM Global Investors’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-48,797
Closed -$2.71M 215
2021
Q1
$2.71M Sell
48,797
-92,265
-65% -$4.18M 0.75% 41
2020
Q4
$4.36M Buy
+141,062
New +$3.36M 1.18% 14
2019
Q2
Sell
-92,899
Closed -$1.63M 159
2019
Q1
$1.63M Sell
92,899
-8,821
-9% -$161K 0.72% 56
2018
Q4
$1.77M Buy
+101,720
New +$1.52M 0.97% 22
2018
Q2
Sell
-98,926
Closed -$984K 184
2018
Q1
$984K Buy
+98,926
New +$818K 0.51% 106

Other funds holding VCEL

EAM Global Investors's VCEL Position: Q2 2021 in Review

EAM Global Investors sold out of Vericel Corp (VCEL) in Q2 2021, closing a stake of 48,797 shares — an estimated $2.71M sold.

EAM Global Investors first reported a position in VCEL in Q1 2018 and held it in 5 quarters. The position peaked at $4.36M in Q4 2020. 205 funds tracked by Wall St. Rank hold VCEL as of Q2 2021.

  • EAM Global Investors reported no remaining Vericel Corp position as of Q2 2021 after selling out during the quarter.
  • EAM Global Investors sold 48,797 Vericel Corp shares in Q2 2021, an estimated $2.71M.
  • EAM Global Investors first reported a position in Vericel Corp in Q1 2018 and held it in 5 quarters.
  • EAM Global Investors's Vericel Corp position peaked at $4.36M in Q4 2020.
  • 205 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2021.

Based on EAM Global Investors's 13F filing for Q2 2021, filed 13 Aug 2021.